NasdaqGM:APEN

Stock Analysis Report

Executive Summary

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices.

Rewards

Loading interface...

Risk Analysis

Loading interface...

Snowflake Analysis

Adequate balance sheet and slightly overvalued.


Similar Companies

Share Price & News

How has Apollo Endosurgery's share price performed over time and what events caused price changes?


Latest Share Price and Events

Information is not available.


Market Performance


7 Day Return

8.9%

APEN

-0.02%

US Medical Equipment

1.3%

US Market


1 Year Return

-27.0%

APEN

22.3%

US Medical Equipment

19.4%

US Market

Information is not available.

Information is not available.


Shareholder returns

APENIndustryMarket
7 Day8.9%-0.02%1.3%
30 Day5.0%3.9%2.6%
90 Day-13.5%3.9%5.0%
1 Year-27.0%-27.0%23.3%22.3%22.0%19.4%
3 Yearn/a90.4%84.7%46.8%37.3%
5 Yearn/a117.4%93.7%66.3%48.0%

Price Volatility Vs. Market

How volatile is Apollo Endosurgery's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Apollo Endosurgery undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is Apollo Endosurgery forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

1.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Apollo Endosurgery performed over the past 5 years?

-4.6%

Historical annual earnings growth


Earnings and Revenue History

Information is not available.

Information is not available.


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Apollo Endosurgery's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Apollo Endosurgery's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Information is not available.

Information is not available.


Stability and Growth of Payments

Information is not available.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Apollo Endosurgery's salary, the management and board of directors tenure and is there insider trading?

5.4yrs

Average management tenure


CEO

Todd Newton (56yo)

5.4yrs

Tenure

US$1,068,801

Compensation

Mr. Todd Newton has been the Chief Executive Officer of Apollo Endosurgery, Inc. since July 1, 2014. Mr. Newton served as the Chief Operating Officer and Chief Financial Officer of ArthroCare Corporation f ...


CEO Compensation Analysis

Information is not available.

Information is not available.


Management Age and Tenure

5.4yrs

Average Tenure

55yo

Average Age

Information is not available.


Board Age and Tenure

5.6yrs

Average Tenure

56yo

Average Age

Information is not available.


Insider Trading

Information is not available.


Recent Insider Transactions

BuyUS$88,35014 May 19
Todd Newton
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares25,000
Max PriceUS$3.53
SellUS$750,00001 Jan 19
Stonepine Capital Management LLC
EntityCompany
Shares250,000
Max PriceUS$3.00
SellUS$1,500,00029 Dec 18
Stonepine Capital Management LLC
EntityCompany
Shares500,000
Max PriceUS$3.00

Ownership Breakdown

Information is not available.


Management Team

  • Sydney Chung

    Co-Founder and Innovation Partner

    • Tenure: 0yrs
  • Jay Pasricha

    Co-Founder

    • Tenure: 14.9yrs
  • Rob Hawes

    Co-Founder and Innovation Partner

    • Tenure: 0yrs
  • Chris Gostout (68yo)

    Co-Founder & Chief Medical Officer

    • Tenure: 0yrs
    • Compensation: US$1.16m
  • Sergey Kantsevoy

    Co-Founder and Innovation Partner

    • Tenure: 0yrs
  • Anthony Kalloo

    Co-Founder and Innovation Partner

    • Tenure: 0yrs
  • Peter Cotton

    Co-Founder and Innovation Partner

    • Tenure: 14.9yrs
  • Stefanie Cavanaugh (54yo)

    CFO, Treasurer & Secretary

    • Tenure: 4.8yrs
    • Compensation: US$520.72k
  • Todd Newton (56yo)

    CEO & Director

    • Tenure: 5.4yrs
    • Compensation: US$1.07m
  • Bret Schwartzhoff (46yo)

    Vice President

    • Tenure: 5yrs
    • Compensation: US$343.00k

Board Members

  • John Barr (62yo)

    Independent Chairman of the Board

    • Tenure: 0.5yrs
  • Matt Crawford (53yo)

    Director

    • Tenure: 13.9yrs
  • Bill McClellan (59yo)

    Director

    • Tenure: 5.6yrs
    • Compensation: US$106.10k
  • Adrian Park

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Mark Talamini

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Todd Newton (56yo)

    CEO & Director

    • Tenure: 5.4yrs
    • Compensation: US$1.07m
  • Santiago Horgan

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Bruce Robertson (56yo)

    Director

    • Tenure: 12.9yrs
  • Jay Redan

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Steve McCarus

    Member of Scientific Advisory Board

    • Tenure: 0yrs

Company Information

Apollo Endosurgery, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Apollo Endosurgery, Inc.
  • Ticker: APEN
  • Exchange: NasdaqGM
  • Founded: 2005
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$61.576m
  • Shares outstanding: 20.94m
  • Website: https://www.apolloendo.com

Number of Employees


Location

  • Apollo Endosurgery, Inc.
  • 1120 South Capital of Texas Highway
  • Building 1
  • Austin
  • Texas
  • 78746
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APENNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDDec 2016
HQ8FDB (Deutsche Boerse AG)YesCommon StockDEEURDec 2016

Biography

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing S ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/12/13 01:14
End of Day Share Price2019/12/12 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.